FI52225C - Process for the preparation of therapeutically useful 15alpha, 16alpha-methylene-4-ester en-17beta-ols. - Google Patents

Process for the preparation of therapeutically useful 15alpha, 16alpha-methylene-4-ester en-17beta-ols.

Info

Publication number
FI52225C
FI52225C FI730169A FI16973A FI52225C FI 52225 C FI52225 C FI 52225C FI 730169 A FI730169 A FI 730169A FI 16973 A FI16973 A FI 16973A FI 52225 C FI52225 C FI 52225C
Authority
FI
Finland
Prior art keywords
15alpha
16alpha
17beta
ols
methylene
Prior art date
Application number
FI730169A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI52225B (en
Inventor
Rudolf Wiechert
Hermann Steinbeck
Walter Elger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to FI770407A priority Critical patent/FI54132C/en
Application granted granted Critical
Publication of FI52225B publication Critical patent/FI52225B/fi
Publication of FI52225C publication Critical patent/FI52225C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI730169A 1972-02-11 1973-01-23 Process for the preparation of therapeutically useful 15alpha, 16alpha-methylene-4-ester en-17beta-ols. FI52225C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI770407A FI54132C (en) 1972-02-11 1977-02-08 FREQUENCY REQUIREMENT FOR THERAPEUTIC USE OF THERAPEUTIC 15ALFA 16ALFA-METHYLENE-4-ESTREN-17BETA-OLER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (en) 1972-02-11 1972-02-11 15?, 16? -Methylene-4-oestrene-17? -ols or acylates, processes for their production and medicaments containing them

Publications (2)

Publication Number Publication Date
FI52225B FI52225B (en) 1977-03-31
FI52225C true FI52225C (en) 1977-07-11

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
FI730169A FI52225C (en) 1972-02-11 1973-01-23 Process for the preparation of therapeutically useful 15alpha, 16alpha-methylene-4-ester en-17beta-ols.

Country Status (29)

Country Link
JP (1) JPS5829317B2 (en)
KR (1) KR780000156B1 (en)
AT (1) AT327413B (en)
AU (1) AU467306B2 (en)
BE (1) BE795241A (en)
CA (1) CA997753A (en)
CH (2) CH590883A5 (en)
CS (1) CS193019B2 (en)
DD (1) DD102379A5 (en)
DE (1) DE2207421C3 (en)
DK (1) DK131037B (en)
EG (1) EG10914A (en)
ES (1) ES410933A1 (en)
FI (1) FI52225C (en)
FR (1) FR2181719B1 (en)
GB (1) GB1425636A (en)
GR (1) GR63160B (en)
HU (1) HU165253B (en)
IE (1) IE37266B1 (en)
IL (1) IL41506A (en)
NL (1) NL177217C (en)
NO (2) NO140304C (en)
PH (1) PH9370A (en)
PL (1) PL81084B1 (en)
RO (1) RO73527A (en)
SE (3) SE403781B (en)
SU (1) SU513628A3 (en)
YU (1) YU35035B (en)
ZA (1) ZA73944B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027636A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-Cyano-18α-homo-19-nor-androst-4-ene derivative, its use and the derivative-containing drug
DE102007027637A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-cyano-19-nor-androst-4-ene derivative, its use and the derivative-containing drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (en) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stackable, rectangular, closed plastic transport container for fine-grained bulk goods and liquids

Also Published As

Publication number Publication date
GR63160B (en) 1979-09-25
NL177217C (en) 1985-08-16
EG10914A (en) 1976-09-30
ZA73944B (en) 1973-11-28
IL41506A (en) 1976-07-30
RO73527A (en) 1982-02-01
IE37266B1 (en) 1977-06-08
AT327413B (en) 1976-01-26
FR2181719B1 (en) 1975-11-21
IL41506A0 (en) 1973-04-30
NL7301974A (en) 1973-08-14
NO140304B (en) 1979-04-30
FR2181719A1 (en) 1973-12-07
YU24373A (en) 1979-12-31
JPS5829317B2 (en) 1983-06-22
NL177217B (en) 1985-03-18
HU165253B (en) 1974-07-27
CS193019B2 (en) 1979-09-17
AU5207673A (en) 1974-08-15
SE409329B (en) 1979-08-13
ATA112473A (en) 1975-04-15
SU513628A3 (en) 1976-05-05
SE7713896L (en) 1977-12-07
NO143065B (en) 1980-09-01
BE795241A (en) 1973-08-09
CH590883A5 (en) 1977-08-31
DK131037B (en) 1975-05-20
SE426834B (en) 1983-02-14
PH9370A (en) 1975-10-22
AU467306B2 (en) 1975-11-27
DD102379A5 (en) 1973-12-12
CA997753A (en) 1976-09-28
YU35035B (en) 1980-06-30
PL81084B1 (en) 1975-08-30
NO782754L (en) 1973-08-14
ES410933A1 (en) 1976-03-01
DE2207421A1 (en) 1973-08-16
KR780000156B1 (en) 1978-05-02
JPS4886856A (en) 1973-11-15
NO143065C (en) 1980-12-10
CH593995A5 (en) 1977-12-30
IE37266L (en) 1973-08-11
SE7514513L (en) 1975-12-22
DE2207421C3 (en) 1981-05-07
NO140304C (en) 1979-08-08
SE403781B (en) 1978-09-04
FI52225B (en) 1977-03-31
DE2207421B2 (en) 1980-07-24
GB1425636A (en) 1976-02-18
DK131037C (en) 1975-10-20

Similar Documents

Publication Publication Date Title
DK134490B (en) Analogous process for the preparation of 2,6-diaminonebularin derivatives.
NL157290B (en) PROCESS FOR THE PREPARATION OF ANTRACHINONE.
BE808733A (en) PROCESS FOR THE PREPARATION OF CYCLOHEXANE-DIONES-1,3
FI52349C (en) A process for the preparation of new therapeutically useful 2beta, 16beta-piperidino-5alpha-androstanes.
FI49827C (en) Process for the preparation of therapeutically active substituted 3-hydroxymethylisoquinolines.
DK134604B (en) Process for the preparation of indenyl-3-acetoglucuronides.
RO71305A (en) PROCESS FOR THE PREPARATION OF D-HALO-6-METHYL-2,8-CYANO- (CARBOXAMIDO) -GEROLINE
DK137639B (en) Analogous process for the preparation of 1-aminomethyl-2,2-diaryl-cyclopropanecarboxamides.
FI52735C (en) Process for the preparation of new pregnadiene-21-acid derivatives.
DK132233B (en) Process for the preparation of antibiotic A-2315.
RO69492A2 (en) PROCESS FOR THE PREPARATION OF PERCENT-METIL-MERCAPTAN
DK131575B (en) Analogous process for the preparation of 2beta-hydroxy-3alpha-aminosteroids.
DK138645B (en) Analogous process for the preparation of sulfamoylphenyl-imidazolidines.
DK131855B (en) Process for the preparation of 3,4-dihydropyridones.
DK135166B (en) Analogous process for the preparation of 2-methyl-5-nitro-imidazoles.
DK129657B (en) Analogous process for the preparation of 3-methylpyrazole-5-carboxamides.
DK134183B (en) Process for the preparation of cellulose-enzyme complexes.
DK132329B (en) Process for the preparation of cardenolide-3, alpha- / 2'-deoxy-glycosides /.
FI52225C (en) Process for the preparation of therapeutically useful 15alpha, 16alpha-methylene-4-ester en-17beta-ols.
DK139677B (en) Process for the preparation of 7-benzoylindolin-2-ones.
DK132410B (en) Analogous process for the preparation of 2-amino-4H-pyranes.
DK134236B (en) Analogous process for the preparation of 3-cycloalkoxy-16alpha-cyanopregn-5-en-20-ones.
CH553216A (en) PROCESS FOR THE PREPARATION OF CETENIMINEPENICILLINS.
CH552620A (en) PROCESS FOR THE PREPARATION OF NEW SUBSTITTED QUINOLEINES.
DK132032B (en) Analogous process for the preparation of 15alpha, 16alpha-methylene-4-pregnenes.